Anti-Infectives Week articles from September 2004

Anti-Infectives Week archives from September 2004

Competitive induction and enhancement hold promise for new antibiotics.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Competitive induction and enhancement of indole and a diketopiperazine in marine bacteria could be a valuable tool in the search for new antibiotics. "Thirteen bacterial strains isolated from a...

Linezolid-associated peripheral neuropathy reported.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers report cases of linezolid-associated peripheral neuropathy in a recent issue of the Mayo Clinic Proceedings. According to a study from the United States, "Linezolid is the first drug in...

Gaps in capacity of serum samples to neutralize S. aureus superantigens.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- There are large gaps in the capacity of human serum samples to neutralize Staphylococcus aureus superantigens. "PCR was employed to determine the presence of all known superantigen genes (sea, seq,...

Cytokine flow cytometry analyzes T-cell responses to cytomegalovirus.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cytokine flow cytometry analyzes T-cell responses to cytomegalovirus. "T-cell responses to human cytomegalovirus (CMV) are readily detected in chronically infected adults, and are thought to be...

Patient-applied home therapy attractive option for treatment of genital warts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patient-applied home therapy is an attractive option for the treatment of genital warts. According to a study from North Ireland, "Genital warts are one of the most commonly reported sexually...

Sustained-release doxycycline provides prophylaxis of tick bite infection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A sustained-release formulation of doxycycline hyclate provides prophylaxis of tick bite infection in a murine model of Lyme borreliosis. According to a study from the United States, " The...

Folding and dimerization of HIV-1 protease yields evidence for stable monomer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The folding and dimerization of HIV-1 protease have yielded evidence for a stable monomer from simulations. "HIV-1 protease (PR) is a major drug target in combating AIDS, as it plays a key role in...

HIV carrying D67N or K219Q/E mutation evolves to zidovudine resistance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of...

Systematic HAART for HIV patients with >500 T cell counts not supported by data.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The data does not support systematic highly active antiretroviral therapy for HIV patients with >500 T cell counts. "To assess the clinical, immunological and virological evolution in HIV-1...

Southeast Asia reports first case of B. mandrillaris meningoencephalitis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Southeast Asia reports its first case of Balamuthia mandrillaris meningoencephalitis. According to a study from Thailand, "We present a case of 23-year-old man with acute meningoencephalitis,...

Aminoglycoside-RNA hairpin interactions have low selectivity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aminoglycoside-RNA hairpin interactions have a low degree of selectivity. "Aminoglycoside antibiotics, which are able to selectively bind to RNA, are considered to be an important lead in...

Resistance to third-generation cephalosporins in Enterobacteriaceae increased.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The resistance to third-generation cephalosporins in Enterobacteriaceae isolates has increased. According to published research from Tunisia, "Between January 1993 and December 2001, the overall...

FDA approves ophthalmic anti-inflammatory/antibiotic combination product.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmos Corp.'s (PARS) former marketing partner, Bausch & Lomb, has received from the U.S. Food and Drug Agency (FDA) an approvable letter for ZyLET, the new drug application which was filed by Bausch &...

Novel AZT and D4T derivatives show efficacy against HIV.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novel AZT and D4T derivatives show efficacy against HIV "Two series of new lipophilic phosphonoformate and phosphonoacetate derivatives of AZT and d4T were synthesized and evaluated as anti-HIV...

Novel drug approaches minimize development of HIV-1 resistance to NNRTIs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novel drug approaches minimize the development of HIV-1 resistance to non-nucleoside reverse transcriptase inhibitors. According to recent research published in the International Journal of...

New vaccine seeks to tame bird flu.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The National Institutes of Health awarded Chiron Corp. a $1.194 million contract to develop up to 40,000 doses of vaccine against H9N2 avian influenza, a type of bird flu that is less lethal but more...

Enterobacter cloacae emerging as a common pathogen in neonatal units.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Enterobacter cloacae is emerging as a common pathogen in neonatal units. According to published research from France, "In the first week of December 2002, three infants hospitalized in the neonatal...

The role of biofilm matrix in structural development is described.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The role of the biofilm matrix in structural development has been described in a recent report. According to researchers in the United States, "Although the initiation, development and control of...

Monitoring R-methadone plasma levels useful for adjusting drug dose.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Monitoring R-methadone plasma levels is useful for adjusting the methadone dose. "A capillary electrophoresis method was developed to detect interactions between methadone and anti-retroviral...

Pharmaceutical firm wins $13.1M biodefense research contract.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Caprion Pharmaceuticals, Inc., has been awarded a U.S. $13.1 million contract by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, to...

Biopharmaceutical company receives delisting notice from Nasdaq.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Citing the postponement of the filing of VaxGen's financial statements for the fiscal quarters ended March 30 and June 30, 2004, which is due to the company implementing what it believes is a more...

Chlamydia managed successfully with telephone follow-up management system.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Chlamydia patients were managed more successfully with a telephone follow-up management system over traditional clinic follow-up. "A retrospective review of 400 cases of genital chlamydia managed...

Companies collaborate to provide needle safety for 2004 season flu vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Edwards Medical Supply and Safety Syringes, Inc., announced a collaboration to aid in the distribution of UltraSafe Needle Guards to purchasers of prefilled syringes of influenza virus vaccine. "We...

Neugene antisense deal inked with USAMRIID on biodefense agents.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced it has signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The...

CMV pp65 protein Ag recognized by CD4 cells induced with immunodominant peptides.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The cytomegalovirus pp65 protein antigen is recognized by CD4 cells induced with immunodominant peptide pools. "Cellular immunity against cytomegalovirus (CMV) is essential for recovery from...

CMV prophylaxis following BMT has changed the natural history of the disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cytomegalovirus prophylaxis following bone marrow transplant has changed the natural history of the disease. "Cytomegalovirus (CMV) is a well-known cause of disease occurring after bone marrow...

CMV viral proteins have adapted by functionally mimicking cellular genes.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cytomegalovirus viral proteins have adapted by functionally mimicking cellular genes. According to a study from France, "The human cytomegalovirus (HCMV) genome has evolved with its host by...

Formation of effector memory CD4+ cells necessary for recovery of CMV infection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Formation of effector memory CD4+ cells is necessary for the recovery of cytomegalovirus infection. According to recent research published in the journal Human Immunology, "The correlates of...

Gene transfer used to activate CMV specific T cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Gene transfer is used to activate cytomegalovirus specific T cells. "Cytomegalovirus (CMV) is responsible for significant morbidity and mortality in immunocompromised patients undergoing allogeneic...

New methods may improve management of late CMV infection following SCT.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- New methods may improve the management of late cytomegalovirus infection following stem cell transplantation. According to recent research published in the journal Human Immunology,...

Biodegradable composite shows promise as antibiotic delivery system.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A novel hydroxyapatite-based composite shows great promise as a biodegradable antibiotic delivery system. In a recent study, researchers in Thailand "investigated the efficacy of a local...

Liposomal benznidazole has similar efficacy to standard formulation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Despite enhanced hepatic uptake, liposomal benznidazole (BNZ) has therapeutic efficacy roughly equal to that of non-liposomal BNZ formulations. "With the aim of investigating if" BNZ delivery "to...

Lyssavirus-based antiviral drug discovery strategy devised.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A novel antiviral drug discovery strategy has been developed and validated. Researchers in France presented "a new strategy for antiviral peptide discovery by using lyssaviruses (rabies virus and...

Novel antifungal compound derived from Phoma species.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A compound with antifungal activity has been isolated from a Phoma fungus. "Through our screening for novel antifungal compounds, YM-215343 was found in the culture extract of Phoma sp. QN04621,"...

Positive phase 3 results announced for dalbavancin in skin, tissue infections.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Vicuron Pharmaceuticals Inc. (MICU) announced results from pivotal phase 3 clinical trials comprising more than 1,500 patients evaluating once-weekly dalbavancin in skin and soft tissue infections...

Mutations conferring drug resistance partially resensitize resistant HIV to AZT.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Point mutations conferring drug resistance partially resensitize resistant HIV to AZT. According to recent research from France, "During zidovudine and stavudine treatment, HIV-1 selects several...

Safety review of endocarditis/bacteremia data for Cubicin completed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced the completion of the third planned safety review of patients enrolled in Cubist's ongoing international phase III clinical trial examining the safety and...

Patent issued for Enterococcus antigens and vaccines.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) has been granted U.S. Patent No. 6,756,361 entitled "Enterococcus Antigens and Vaccines" by the U.S. Patent and Trademark Office. The patent covers the composition of...

EBNA-2 gene variant may play role in pathogenesis of oral hairy leukoplakia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- An EBNA-2 gene variant may play a role in the pathogenesis of oral hairy leukoplakia. A retrospective study from the United States "examined expression of Epstein-Barr virus (EBV) latent genes in...

$1.4M grant awarded from DOD for anti-microbial coating.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Bacterin International, Inc., a developer and manufacturer of elutive bioactive coatings for medical devices, announced that the Department of Defense has awarded the company $1.4 million in DOD...

Biopharmaceutical company announces financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) reported financial results for the second quarter of 2004. For the second quarter ended June 26, 2004, the company reported a net loss of...

Food Technology Service reports Q2 revenues of $324,384.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Food Technology Service, Inc., (VIFL) announced results for the second quarter and the first half of the fiscal year ending June 30, 2004. Second-quarter revenues were $324,384 compared to $587,999...

In Q4, total revenue increased 36% to $25.9 million for HPV testmaker.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Digene Corp. (DIGE) reported record financial results for the fourth quarter and year ended June 30, 2004. For the fiscal 2004 fourth quarter, total revenue increased 36% to $25.9 million from...

RNA interference thwarts the virus that causes SARS.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- RNA interference thwarts the virus that causes SARS. According to published research from the Peoples Republic of China, "severe acute respiratory syndrome (SARS) is an acute respiratory infectious...

Study says genetic tests could make donated tissue safer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Just a single donor's tissue might slip through each year infected with HIV or hepatitis, but U.S. donations could be made even safer with genetic testing for the viruses, researchers have found. ...

Aerobic exercise dysfunction in HIV is potential link to physical disability.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aerobic exercise dysfunction in HIV-infected persons is a potential link to physical disability. According to recent research published in the journal Physical Therapy, "Approximately 282,000...

Free antiretroviral therapy distributed to six most needy states in India.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Free antiretroviral therapy is being distributed to the six most needy states in India. According to recent research from the United States, "India has a population of more than 1 billion people....

HIV infections increasing in vulnerable areas of Cambodia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infections are increasing in vulnerable areas of Cambodia. According to published research from the United States, "In the past decade, Cambodia has been experiencing the most serious HIV/AIDS...

Components of successful HIV/AIDS case management Alaskan villages identified.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The components of successful HIV/AIDS case management in Alaskan villages have been identified. "Case management is a valuable support service for HIV/AIDS patients, but little is known about the...

HIV infection increased 15% per year since 1997 in Taiwan.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infection has increased 15% per year since 1997 in Taiwan. According to a study from Taiwan, "The HIV/AIDS epidemic in Taiwan started in 1986, with 5,221 cases of HIV infections, 1,596 cases of...

New HIV infections increasing among young men in Hong Kong.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- New HIV infections are increasing among young men in Hong Kong. "Hong Kong is an area with low HIV prevalence. Public health services provided through the methadone clinics and public sexually...

HIV/hepatitis prevention urgently needed in drug treatment programs in Hungary.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV and hepatitis prevention is urgently needed in drug treatment programs in Hungary. According to published research from the United States, "We assess HIV and hepatitis testing and counseling in...

CXCR4 dimerization involved in SDF-1alpha- and gp120-induced signaling events.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CXCR4 dimerization is involved in SDF-1alpha- and gp120-induced signaling events. "Both the chemokine SDF-1alpha and the human immunodeficiency virus-1 (HIV-1) coat protein gp120 can bind to CXCR4...

Filgrastim activates replication of minor variants of HIV-1.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Filgrastim activates the replication of minor variants of HIV-1. According to a study from the United States, "The hypothesis that filgrastim (r-met-huG-CSF) activates replication of minor variants...

HIV protease inhibitors are inhibitors but not substrates of BCRP/ABCG2.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV protease inhibitors are inhibitors of but not substrates of the human breast cancer resistance protein (BCRP/ABCG2. According to published research from the United States, "Breast cancer...

HIV-1 promotes quiescence in human neural progenitor cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV-1 promotes quiescence in human neural progenitor cells. "The exact mechanism by which human immunodeficiency virus type 1 (HIV-1) produces dementia remains obscure. We have recently found that...

Host factor Sam68 enhances HIV-1 RNA 3' end processing.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Host factor Sam68 enhances HIV-1 RNA 3' end processing. "Both cis elements and host cell proteins can significantly affect HIV-1 RNA processing and viral gene expression. Previously, we...

LNA/DNA chimeric oligomers mimic RNA aptamers targeted to HIV TAR RNA.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- LNA/DNA chimeric oligomers mimic RNA aptamers targeted to HIV TAR RNA. "One of the major limitations of the use of phosphodiester oligonucleotides in cells is their rapid degradation by nucleases....

Several factors serve as determinants of sensitivity to HIV fusion inhibitors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Several factors serve as determinants of sensitivity to HIV fusion inhibitors. "C-peptides derived from the HIV envelope glycoprotein transmembrane subunit gp41 C-terminal heptad repeat (C-HR)...

AIDS infection increasing via heterosexual transmission in Malaysia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AIDS infection increasing via heterosexual transmission in Malaysia. According to a study from Malaysia, "Since the first case of HIV/AIDS was identified in 1986 in Malaysia, the number of infected...

Nigeria aims to spend $248 million providing HIV treatment to 200,000 sufferers.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Africa's most populous nation plans to spend $248 million on AIDS drugs for 200,000 HIV-infected Nigerians by the end of 2005, according to Health Minister Eyitayo Lambo. Aside from procuring the...

HAART improves outcome of HIV-associated plasmablastic lymphoma of oral cavity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- "Plasmablastic lymphoma (PBL) is a recently described type of non-Hodgkin lymphoma (NHL) that occurs in up to 3% of patients with HIV infection. Although the clinical-pathological features of several...

Pneumocystosis still major health problem for HIV-positive and -negative patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pneumocystosis is still a major health problem for HIV-positive and -negative patients. "In order to investigate the impact of Pneumocystis carinii infection in southern Spain following the...

Low genetic diversity despite hyperendemicity of HBV genotype E in West Africa.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- There is a low genetic diversity despite a hyperendemicity of hepatitis B viru genotype E in West Africa. According to recent research from Luxembourg, "Sub-Saharan Africa suffers from an...

Close association between circulating cytokines and viral-induced malignancy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- There is a close association between circulating cytokines and viral-induced malignancy. According to a study from England, "A 32-year-old HIV-1 positive man was diagnosed with Castleman disease...

California's West Nile virus cases jump.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The number of people infected with the West Nile virus in California has jumped by 32% in nearly a week, according to state officials. There are now 249 reported cases in California, up from 189 on...

Health department identifies more victims of Ohio island illness.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers have found more cases of an illness that's causing cramps, diarrhea, nausea, fever and chills among visitors to this resort area, according to the Ohio Department of Health. The number...

Montana woman diagnosed with West Nile.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Health officials in Custer County announced Montana's first human West Nile virus case of the year. The unidentified woman complained to her doctor of headaches, body aches, a rash and malaise,...

Taiwan battles dengue fever.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Taiwanese health workers have sprayed insecticide and inspected homes in a southern city that reported 3 new cases of dengue fever - a mosquito-borne disease that can be fatal if untreated. The...

Four resistance factors identified in interferon inhibitory activity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Four resistance factors have been identified in interferon inhibitory activity. According to a study from the United States, "Interferon (IFN) resistance is an important factor in the...

Toll-like receptor 4 contributes to efficient control of Leishmania growth.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Toll-like receptor 4 contributes to the efficient control of Leishmania growth. According to recent research published in the Journal of Leukocyte Biology, "The innate immune system is essential for...

Hepatocellular carcinomas likely to increase in HIV/HBV coinfected patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatocellular carcinomas are likely to increase in HIV/HBV coinfected patients. According to recent research from the United States, "Infections with hepatitis B virus (HBV) and human...

Artesunate plus amodiaquine effective for treatment of uncomplicated malaria.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Artesunate plus amodiaquine are effective for the treatment of uncomplicated malaria. According to recent research from Switzerland, "Faced with the problem of resistance to chloroquine and...

Merger between Vitex and Panacos Pharmaceuticals endorsed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc., (NASDAQ:VITX) (Vitex) announced that it has learned that Institutional Shareholder Services, Inc., (ISS) has recommended to its clients that they vote for the merger agreement...

Drug resistance mechanisms can reveal novel targets for antiretroviral agents.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Drug resistance mechanisms can reveal novel targets for antiretroviral agents. "HIV reverse transcriptase (RT) is the target of a number of important anti-AIDS drugs. Drugs that inhibit RT are...

Transporters play significant role in absorption and disposition of drugs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Transporters play a significant role in the absorption and disposition of drugs. According to a study from the United States, "...in vitro and in vivo data were provided for saquinavir (SQV) showing...

Experts work to identify mystery disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Top experts in mad cow-like diseases are trying to identify a strain discovered in a patient at Harborview Medical Center this summer. It was clearly not the human form of mad cow, nor does it...

Woman dies of mad cow-type disease in Seattle.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A woman being treated for a brain-wasting condition believed to be related to mad cow disease has died, and an autopsy may help identify the ailment, authorities said. Brain tissue from the woman...

Arizona State University receives federal grant for STD drug research.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Arizona State University's new Biodesign Institute is getting a 5-year, $7.4 million federal grant to work on drugs that kill sexually transmitted diseases like AIDS. ASU is working with the...

Disposables/reusables dynamic affects disposable drapes and gowns markets.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device...

BLA submitted to FDA for Adacel vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aventis (AVE) announced the submission of a Biologics Licensing Application (BLA) to the U.S. Food and Drug Administration (FDA) for marketing approval of Adacel (Tetanus Toxoid and Reduced Diphtheria...

Colleges urge students to protect themselves against meningitis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Health officials are hoping college students will add one more thing to their back-to-school list: a meningitis vaccination. The University of Kansas is, for the first time, encouraging students...

Human West Nile cases slow in Arizona.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The spread of West Nile virus in Arizona appears to have hit a plateau, with only 13 new cases reported, according to state health officials. The state has reported 294 of the nation's 689 human...

Seven new West Nile cases confirmed in New Mexico.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- New Mexico has reported 7 more cases of West Nile virus, bringing the total for the year to 21. All of the new patients are recovering. All but one of them - an 84-year-old Dona Ana County man -...